SCHEMBL469416

SCHEMBL469416

C=NNC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12290808 0.67
Formaldehyde SCHEMBL1044592 0.60
SCHEMBL29236157 0.59
SCHEMBL441023 0.59
SCHEMBL6955183 0.59
SCHEMBL4405963 0.56
SCHEMBL16842676 0.56
SCHEMBL1304469 0.56
SCHEMBL16072423 0.56
SCHEMBL12730599 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024126840-A1 NOVEL COMPOUNDS FOR DIAGNOSIS AC IMMUNE SA (CH) 2024-06-20 WO disclosed
WO-2024102999-A2 SMALL MOLECULE INHIBITORS FOR THE TREATMENT AND PREVENTION OF CORONAVIRUS INFECTIONS OHIO STATE INNOVATION FOUNDATION (US) 2024-05-16 WO disclosed
WO-2023116888-A1 FIVE- AND SIX-MEMBERED COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE 杭州多域生物技术有限公司 2023-06-29 WO disclosed
EP-4166299-A1 FIBER-DISPERSING RESIN COMPOSITE MATERIAL, MOLDED BODY, AND COMPOSITE MEMBER Furukawa Electric Co., Ltd. (JP) 2023-04-19 EP disclosed
WO-2022204184-A1 ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS NUVATION BIO INC. (US) 2022-09-29 WO disclosed
US-11130758-B2 Tetrahydropyrazolopyrimidine compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2021-09-28 US disclosed
US-20210220784-A1 A CARBON DIOXIDE FLUIDITY CONTROL DEVICE AND METHOD CHINA UNIVERSITY OF PETROLEUM (EAST CHINA) (CN) 2021-07-22 US disclosed
US-10940474-B2 Oxidant sensor UNIVERSITY OF SOUTH AUSTRALIA (AU) 2021-03-09 US disclosed
EP-3753578-A1 CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF Novartis AG (CH) 2020-12-23 EP disclosed
US-20200347050-A1 TETRAHYDROPYRAZOLOPYRIMIDINE COMPOUNDS EISAI R&D MANAGEMENT CO., LTD. (JP) 2020-11-05 US disclosed
US-7235561-B2 Compound and a composition including such a compound SCHERING AG (DE) 2007-06-26 US disclosed
US-20070141358-A1 Method for improving the edging of an optical article by providing a temporary layer of an organic material ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE 2007-06-21 US disclosed
WO-2007056468-A1 METHODS FOR INHIBITING PROTEIN KINASES SCHERING CORPORATION (US) 2007-05-18 WO disclosed
WO-2007041520-A2 METHODS FOR DIRECT PROTEIN IDENTIFICATION BY MALDI NEW YORK UNIVERSITY (US) 2007-04-12 WO disclosed
EP-1757608-A1 New benzazepine derivatives, medicaments containing the same and their use in the preparation of medicaments Sanochemia Pharmazeutika Aktiengesellschaft (AT) 2007-02-28 EP disclosed
EP-1717239-A1 SUBSTITUTED SYM-TRIINDOLE Ihara Chemical Industry Co., Ltd. (JP) 2006-11-02 EP disclosed
EP-0877737-B1 NOVEL N-(ARYLSULPHONYL)AMINO ACID DERIVATIVES HAVING BRADYKININ RECEPTOR AFFINITY SANOFI SYNTHELABO (FR) 2001-08-01 EP disclosed
WO-2000047579-A1 SUBSTITUTED BENZTHIAZOLYLALKYLAMINO-1,3,5-TRIAZINES AS HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 2000-08-17 WO disclosed
EP-0877737-A1 NOVEL N-(ARYLSULPHONYL)AMINO ACID DERIVATIVES HAVING BRADYKININ RECEPTOR AFFINITY SANOFI (FR) 1998-11-18 EP disclosed
WO-1997025315-A1 NOVEL N-(ARYLSULPHONYL)AMINO ACID DERIVATIVES HAVING BRADYKININ RECEPTOR AFFINITY SANOFI (FR) 1997-07-17 WO disclosed